Insider Transactions in Q3 2024 at Brp Group, Inc. (BRP)
Insider Transaction List (Q3 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Aug 30
2024
|
Lowry Baldwin Director |
SELL
Open market or private sale
|
Indirect |
50,000
-100.0%
|
$2,300,000
$46.74 P/Share
|
Aug 30
2024
|
Lowry Baldwin Director |
BUY
Conversion of derivative security
|
Indirect |
50,000
+50.0%
|
-
|
Aug 30
2024
|
Lowry Baldwin Director |
SELL
Conversion of derivative security
|
Indirect |
50,000
-100.0%
|
-
|
Aug 30
2024
|
Lowry Baldwin Director |
BUY
Other acquisition or disposition
|
Indirect |
50,000
+50.0%
|
-
|
Aug 30
2024
|
Lowry Baldwin Director |
SELL
Other acquisition or disposition
|
Indirect |
71,500
-0.27%
|
-
|
Aug 30
2024
|
Baldwin Insurance Group Holdings, LLC > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
71,500
-0.27%
|
-
|
Aug 29
2024
|
Daniel Galbraith Officer |
SELL
Open market or private sale
|
Indirect |
75,000
-100.0%
|
$3,450,000
$46.33 P/Share
|
Aug 29
2024
|
Daniel Galbraith Officer |
BUY
Conversion of derivative security
|
Indirect |
75,000
+50.0%
|
-
|
Aug 29
2024
|
Daniel Galbraith Officer |
SELL
Conversion of derivative security
|
Indirect |
75,000
-6.2%
|
-
|
Aug 29
2024
|
Chris Thomas Sullivan Director |
SELL
Bona fide gift
|
Direct |
10,000
-10.72%
|
-
|
Aug 27
2024
|
Chris Thomas Sullivan Director |
SELL
Bona fide gift
|
Direct |
1,352
-1.43%
|
-
|
Aug 21
2024
|
Lowry Baldwin Director |
SELL
Open market or private sale
|
Indirect |
28,256
-100.0%
|
$1,215,008
$43.05 P/Share
|
Aug 20
2024
|
Lowry Baldwin Director |
SELL
Open market or private sale
|
Indirect |
51,744
-33.0%
|
$2,173,248
$42.93 P/Share
|
Aug 19
2024
|
James Morgan Roche Officer |
SELL
Open market or private sale
|
Direct |
75,380
-23.03%
|
$3,165,960
$42.87 P/Share
|
Aug 16
2024
|
James Morgan Roche Officer |
SELL
Open market or private sale
|
Direct |
150,000
-25.31%
|
$6,300,000
$42.12 P/Share
|
Aug 15
2024
|
James Morgan Roche Officer |
SELL
Open market or private sale
|
Direct |
111,591
-13.0%
|
$4,575,231
$41.81 P/Share
|
Aug 15
2024
|
Bradford Hale Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
10,000
-9.25%
|
$410,000
$41.49 P/Share
|
Aug 14
2024
|
James Morgan Roche Officer |
BUY
Conversion of derivative security
|
Direct |
200,000
+30.97%
|
-
|
Aug 14
2024
|
James Morgan Roche Officer |
SELL
Conversion of derivative security
|
Direct |
200,000
-16.17%
|
-
|
Aug 14
2024
|
James Morgan Roche Officer |
SELL
Open market or private sale
|
Direct |
2,547
-1.03%
|
$104,427
$41.45 P/Share
|
Aug 13
2024
|
Lowry Baldwin Director |
SELL
Open market or private sale
|
Indirect |
20,000
-20.0%
|
$820,000
$41.36 P/Share
|
Aug 13
2024
|
James Morgan Roche Officer |
SELL
Open market or private sale
|
Direct |
6,317
-2.48%
|
$258,997
$41.28 P/Share
|
Aug 12
2024
|
Lowry Baldwin Director |
BUY
Conversion of derivative security
|
Indirect |
100,000
+50.0%
|
-
|
Aug 12
2024
|
Lowry Baldwin Director |
SELL
Conversion of derivative security
|
Indirect |
100,000
-100.0%
|
-
|
Aug 12
2024
|
Lowry Baldwin Director |
BUY
Other acquisition or disposition
|
Indirect |
100,000
+50.0%
|
-
|
Aug 12
2024
|
Lowry Baldwin Director |
SELL
Other acquisition or disposition
|
Indirect |
100,000
-0.76%
|
-
|
Aug 12
2024
|
Baldwin Insurance Group Holdings, LLC > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
100,000
-0.76%
|
-
|
Aug 12
2024
|
James Morgan Roche Officer |
SELL
Open market or private sale
|
Direct |
85,222
-25.07%
|
$3,494,102
$41.5 P/Share
|
Aug 09
2024
|
James Morgan Roche Officer |
SELL
Open market or private sale
|
Direct |
56,912
-14.34%
|
$2,333,392
$41.92 P/Share
|
Aug 08
2024
|
Seth Bala Cohen General Counsel |
SELL
Open market or private sale
|
Direct |
3,783
-30.03%
|
$158,886
$42.63 P/Share
|
Aug 08
2024
|
James Morgan Roche Officer |
SELL
Open market or private sale
|
Direct |
36,684
-4.32%
|
$1,540,728
$42.03 P/Share
|
Aug 08
2024
|
James Morgan Roche Officer |
BUY
Conversion of derivative security
|
Direct |
200,000
+31.57%
|
-
|
Aug 08
2024
|
James Morgan Roche Officer |
SELL
Conversion of derivative security
|
Direct |
200,000
-13.92%
|
-
|
Aug 01
2024
|
Seth Bala Cohen General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,217
-8.81%
|
$52,331
$43.21 P/Share
|
Jul 01
2024
|
Jay A Cohen Director |
BUY
Grant, award, or other acquisition
|
Direct |
547
+4.36%
|
-
|
Jul 01
2024
|
Joseph John Kadow Director |
BUY
Grant, award, or other acquisition
|
Direct |
547
+4.04%
|
-
|
Jul 01
2024
|
Barbara Ruth Matas Director |
BUY
Grant, award, or other acquisition
|
Direct |
547
+4.04%
|
-
|
Jul 01
2024
|
Sathish Muthukrishnan Director |
BUY
Grant, award, or other acquisition
|
Direct |
547
+13.06%
|
-
|
Jul 01
2024
|
Sunita Parasuraman Director |
BUY
Grant, award, or other acquisition
|
Direct |
547
+6.53%
|
-
|
Jul 01
2024
|
Ellyn Shook Director |
BUY
Grant, award, or other acquisition
|
Direct |
547
+6.53%
|
-
|
Jul 01
2024
|
Myron K Williams Director |
BUY
Grant, award, or other acquisition
|
Direct |
547
+6.53%
|
-
|
Jul 01
2024
|
Chris Thomas Sullivan Director |
BUY
Grant, award, or other acquisition
|
Direct |
547
+0.57%
|
-
|